India's Healthcare Spending Prioritizes Treatment Over Prevention

India's healthcare system favors curative care, with 38% of spending going towards in-patient services and treatments, compared to just 14% for preventative care. Healthcare costs are also rising, with claim sizes up 11.4% and medical inflation at...

Indian Pharma Sector Posts 10% YoY Growth in Q2 FY25

The country's top pharmaceutical companies experienced a 10 per cent year-on-year (YoY) growth in the second quarter of FY25, mainly due to their strong performance in North America and the domestic market, as per Axis Securities report...

Indian Pharma Firms Attracts 5,260 Crore Investment, Fuels 12,490 New Jobs

Indian pharmaceutical firms have pledged to invest more than Rs 5,260 crore, with the goal of generating 12,490 job openings within the pharmaceutical industry. The Telangana government has announced that six well-known pharmaceutical companies...

The Fusion of Biology, Medicine, Health, and AI

Researcher and CEO of Arc Fusion, David Ewing Duncan, while speaking at Bengaluru Tech Summit 2024, talked about the idea of super convergence where technologies like AI, genomics, and synthetic biology are coming together to change health and hum...

India's Pharma Sector Faces Decline in Licensing and Technology Transfers

The Indian pharmaceutical industry, known as the ‘pharmacy of the world’, has faced a trend of negative net voluntary licensing and technology transfers – constructive for medicine access in LMICs, according to the 2024 Access to Medicine Index. Rele

Quality Control Innovations Driving Pharma Excellence and Safety

The rapid advancements in quality control techniques and testing methods have been driven by the rising need for safe, effective medications of high quality. The market is growing due to increased attention on product quality and adherence to...

Respiratory Therapies Set to Drive Pharma Growth in Coming Months

Anti-diabetics and cardiac treatments are the main drivers of the domestic pharmaceutical market, with respiratory treatments projected to be the primary growth drivers in November, December, and January. With air pollution persisting, it is...

Pharmanovia Secures Exclusive Rights for Innovative Antibody

The exclusive license agreement permits Pharmanovia to launch catumaxomab, a unique trifunctional bi-specific monoclonal antibody, for intraperitoneal treatment of malignant ascites in EpCAM-positive carcinoma patients ineligible for additional...

Pharma Blister Packaging Adopts Smart Tech for a Future-Ready Market

There is a noticeable shift towards smart packaging technologies in the pharmaceutical blister packaging market. The trend of incorporating digital functions like tracking products using smartphones and reminding patients to take medication on...

China Advances Pharma Innovation for Greater Drug Accessibility

China is upgrading its pharmaceutical industry to make drugs and healthcare more accessible. This is part of its plan to become more self-reliant through “new quality productive forces” driven by technical innovation and a supportive business...